EDESA BIOTECH, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
EDESA BIOTECH, INC. (EDSA) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $41.70 thousand for the 12-month period ending 2018-09-30, per its 10-K filed 2018-11-30.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2018-11-30
- EDESA BIOTECH, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2018 was $41.70K, a 39.00% increase from fiscal 2017.
- EDESA BIOTECH, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2017 was $30.00K.
- EDESA BIOTECH, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2016 was -$67.40K, a 196.98% decline from fiscal 2015.
- EDESA BIOTECH, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2015 was $69.50K, a 72.05% decline from fiscal 2014.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 1 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|---|
| 2018-09-30 | $41.70K 10-K · filed 2018-11-30 | |
| 2017-09-30 | $30.00K 10-K · filed 2018-11-30 | |
| 2016-09-30 | -$67.40K 10-K · filed 2017-12-01 | |
| 2015-09-30 | $69.50K 10-K · filed 2017-12-01 | |
| 2014-09-30 | $9.50K 10-K · filed 2016-12-14 | |
| 2014-08-31 | $248.70K 10-K · filed 2016-12-14 | |
| 2013-08-31 | $327.00K 10-K · filed 2015-12-14 | |
| 2012-08-31 | $549.90K 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |